LIN28B-mediated expression of fetal hemoglobin and production of fetal-like erythrocytes from adult human erythroblasts ex vivo

Blood

Volumn 122, Issue 6, 2013, Pages 1034-1041

  Lee, Y Terry ^a   De Vasconcellos, Jaira F ^a   Yuan, Joan ^b   Byrnes, Colleen ^a   Noh, Seung Jae ^a   Meier, Emily R ^a   Kim, Ki Soon ^a   Rabel, Antoinette ^a   Kaushal, Megha ^a   Muljo, Stefan A ^b   Miller, Jeffery L ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE I; CD71 ANTIGEN; GLUCOSAMINYL (N ACETYL)TRANSFERASE 2; GLYCOPHORIN A; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN DELTA CHAIN; HEMOGLOBIN EPSILON CHAIN; HEMOGLOBIN F; HEMOGLOBIN GAMMA CHAIN; HEMOGLOBIN ZETA CHAIN; KLF1 PROTEIN; LET 7A PROTEIN; LET 7B PROTEIN; LET 7C PROTEIN; LET 7D PROTEIN; LET 7E PROTEIN; LET 7G PROTEIN; LET 7I PROTEIN; LIN28B PROTEIN; MICRORNA; MICRORNA 142; MICRORNA 144; MICRORNA 451; MICRORNA 96; PROTEIN; SOMATOMEDIN B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BCL11A; TRANSCRIPTION FACTOR SOX6; TRANSFERASE; UNCLASSIFIED DRUG; CD34 ANTIGEN; DNA BINDING PROTEIN; HEMOGLOBIN A; LIN28B PROTEIN, HUMAN; MIRN96 MICRORNA, HUMAN; MIRNLET7 MICRORNA, HUMAN; N ACETYLGLUCOSAMINYLTRANSFERASE;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROPOIESIS; EX VIVO STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETICULOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD; CULTURE TECHNIQUE; CYTOLOGY; ERYTHROCYTE; FETUS BLOOD; GENE EXPRESSION REGULATION; METABOLISM;

ANTIGENS, CD34; CARBONIC ANHYDRASE I; CELL CULTURE TECHNIQUES; DNA-BINDING PROTEINS; ERYTHROBLASTS; ERYTHROCYTES; FETAL BLOOD; FETAL HEMOGLOBIN; GENE EXPRESSION REGULATION; HEMOGLOBIN A; HUMANS; MICRORNAS; N-ACETYLGLUCOSAMINYLTRANSFERASES; PHENOTYPE;

EID: 84886898377     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-12-472308     Document Type: Article

References (50)

1. Schechter AN. Hemoglobin research and the origins of molecular medicine. Blood. 2008; 112(10):3927-3938.
2. Ley TJ, DeSimone J, Anagnou NP, et al. 5-azacytidine selectively increases gamma-globin synthesis in a patient with beta1 thalassemia. N Engl J Med. 1982;307(24):1469-1475.
3. Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest. 1984;74(2):652-656.
4. Noguchi CT, Schechter AN. The intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease. Blood. 1981; 58(6):1057-1068.
5. Brittenham GM, Schechter AN, Noguchi CT. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes. Blood. 1985;65(1): 183-189.
6. Weatherall DJ. Pathophysiology of thalassaemia. Baillieres Clin Haematol. 1998;11(1):127-146.
7. Menzel S, Garner C, Gut I, et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet. 2007;39(10):1197-1199.
8. Thein SL, Menzel S, Peng X, et al. Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc Natl Acad Sci USA. 2007;104(27): 11346-11351.
9. Sedgewick AE, Timofeev N, Sebastiani P, et al. BCL11A is a major HbF quantitative trait locus in three different populations with betahemoglobinopathies. Blood Cells Mol Dis. 2008; 41(3):255-258.
10. Uda M, Galanello R, Sanna S, et al. Genomewide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci USA. 2008;105(5):1620-1625.
11. Sankaran VG, Menne TF, Xu J, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science. 2008;322(5909):1839-1842.
12. Moss EG, Lee RC, Ambros V. The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell. 1997;88(5):637-646.
13. Moss EG, Tang L. Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Dev Biol. 2003;258(2):432-442.
14. Guo Y, Chen Y, Ito H, Watanabe A, Ge X, Kodama T, Aburatani H. Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene. 2006; 384:51-61.
15. Lettre G, Jackson AU, Gieger C, et al; Diabetes Genetics Initiative; FUSION; KORA; Prostate, Lung Colorectal and Ovarian Cancer Screening Trial; Nurses' Health Study; SardiNIA. Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet. 2008;40(5):584-591.
16. He C, Kraft P, Chen C, et al. Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet. 2009;41(6):724-728.
17. Ong KK, Elks CE, Li S, et al. Genetic variation in LIN28B is associated with the timing of puberty. Nat Genet. 2009;41(6):729-733.
18. Sulem P, Gudbjartsson DF, Rafnar T, et al. Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche. Nat Genet. 2009;41(6):734-738.
19. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858): 1917-1920.
20. Polesskaya A, Cuvellier S, Naguibneva I, Duquet A, Moss EG, Harel-Bellan A. Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev. 2007;21(9):1125-1138.
21. Heo I, Joo C, Cho J, Ha M, Han J, Kim VN. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell. 2008;32(2):276-284.
22. Piskounova E, Viswanathan SR, Janas M, et al. Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28. J Biol Chem. 2008;283(31): 21310-21314.
23. Viswanathan SR, Powers JT, Einhorn W, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet. 2009;41(7):843-848.
24. Noh SJ, Miller SH, Lee YT, et al. Let-7 microRNAs are developmentally regulated in circulating human erythroid cells. J Transl Med. 2009;7:98.
25. Wilbert ML, Huelga SC, Kapeli K, et al. LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing factor abundance. Mol Cell. 2012;48(2):195-206.
26. Xu J, Shao Z, Glass K, et al. Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis. Dev Cell. 2012; 23(4):796-811.
27. Yuan J, Nguyen CK, Liu X, Kanellopoulou C, Muljo SA. Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. Science. 2012;335(6073): 1195-1200.
28. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods. 2007;4(9): 721-726.
29. Tanno T, Porayette P, Sripichai O, et al. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood. 2009;114(1): 181-186.
30. Sripichai O, Kiefer CM, Bhanu NV, et al. Cytokinemediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming. Blood. 2009;114(11):2299-2306.
31. Brady HJ, Edwards M, Linch DC, Knott L, Barlow JH, Butterworth PH. Expression of the human carbonic anhydrase I gene is activated late in fetal erythroid development and regulated by stagespecific trans-acting factors. Br J Haematol. 1990; 76(1):135-142.
32. Marsh WL. Anti-i: a cold antibody defining the Ii relationship in human red cells. Br J Haematol. 1961;7:200-209.
33. Piller F, Cartron JP, Maranduba A, Veyrières A, Leroy Y, Fournet B. Biosynthesis of blood group I antigens. Identification of a UDP-GlcNAc:GlcNAc beta 1-3Gal(-R) beta 1-6(GlcNAc to Gal) Nacetylglucosaminyltransferase in hog gastric mucosa. J Biol Chem. 1984;259(21): 13385-13390.
34. Inaba N, Hiruma T, Togayachi A, et al. A novel I-branching beta-1,6-Nacetylglucosaminyltransferase involved in human blood group I antigen expression. Blood. 2003; 101(7):2870-2876.
35. Newman MA, Thomson JM, Hammond SM. Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA. 2008;14(8):1539-1549.
36. Eda A, Tamura Y, Yoshida M, Hohjoh H. Systematic gene regulation involving miRNAs during neuronal differentiation of mouse P19 embryonic carcinoma cell. Biochem Biophys Res Commun. 2009;388(4):648-653.
37. Helland Å, Anglesio MS, George J, et al; Australian Ovarian Cancer Study Group. Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers. PLoS ONE. 2011;6(4): e18064.
38. Weedon MN, Lettre G, Freathy RM, et al; Diabetes Genetics Initiative; Wellcome Trust Case Control Consortium. A common variant of HMGA2 is associated with adult and childhood height in the general population. Nat Genet. 2007; 39(10):1245-1250.
39. Cavazzana-Calvo M, Payen E, Negre O, et al. Transfusion independence and HMGA2 activation after gene therapy of human b-thalassaemia. Nature. 2010;467(7313):318-322.
40. Chou S, Lodish HF. Fetal liver hepatic progenitors are supportive stromal cells for hematopoietic stem cells. Proc Natl Acad Sci USA. 2010; 107(17):7799-7804.
41. Azzouzi I, Moest H, Winkler J, et al. MicroRNA-96 directly inhibits g-globin expression in human erythropoiesis. PLoS ONE. 2011;6(7):e22838.
42. Thein SL, Menzel S. Discovering the genetics underlying foetal haemoglobin production in adults. Br J Haematol. 2009;145(4):455-467.
43. Zhou D, Liu K, Sun CW, Pawlik KM, Townes TM. KLF1 regulates BCL11A expression and gammato beta-globin gene switching. Nat Genet. 2010; 42(9):742-744.
44. Richards M, Tan SP, Tan JH, Chan WK, Bongso A. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells. 2004; 22(1):51-64.
45. Nienhuis AW, Stamatoyannopoulos G. Hemoglobin switching. Cell. 1978;15(1):307-315.
46. Wood WG, Bunch C, Kelly S, Gunn Y, Breckon G. Control of haemoglobin switching by a developmental clock? Nature. 1985; 313(6000):320-323.
47. Wilber A, Hargrove PW, Kim YS, et al. Therapeutic levels of fetal hemoglobin in erythroid progeny of b-thalassemic CD341 cells after lentiviral vector-mediated gene transfer. Blood. 2011;117(10):2817-2826.
48. Xu J, Peng C, Sankaran VG, et al. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science. 2011; 334(6058):993-996.
49. Huang Y. A mirror of two faces: Lin28 as a master regulator of both miRNA and mRNA. Wiley Interdiscip Rev RNA. 2012;3(4):483-494.
50. Hafner M, Max KE, Bandaru P, et al. Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition. RNA. 2013;19(5):613-626.